USSTOCK.TODAY
Weekend. Closed Log in Sign up

NanoViricides Inc(NNVC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

NNVC
NNVC
NanoViricides Inc
At close Nov 20 at 4:00 PM ET (Korea 11/21 06:00)
$1.14
-0.03 ▼ -2.56%
Nov 20 at 7:55 PM ET (Korea 11/21 09:55)
$1.13
-0.01 ▼ -0.88%

Full metrics table

Index ⓘ -P/E ⓘ -EPS (ttm) ⓘ -0.54Insider Own ⓘ 2.49%Shs Outstand ⓘ 25.6MPerf Week ⓘ -7.32%
Market Cap ⓘ 0.03BForward P/E ⓘ -EPS next Y ⓘ -Insider Trans ⓘ -Shs Float ⓘ 24.9MPerf Month ⓘ -17.99%
Enterprise Value ⓘ 0.03BPEG ⓘ -EPS next Q ⓘ 0.23Inst Own ⓘ 9.1%Short Float ⓘ 3.26%Perf Quarter ⓘ -10.24%
Income ⓘ -0.01BP/S ⓘ -EPS this Y ⓘ -12.2%Inst Trans ⓘ 2.17%Short Ratio ⓘ 2.27Perf Half Y ⓘ -30.49%
Sales ⓘ 0.00BP/B ⓘ 4.54EPS next 5Y ⓘ -ROA ⓘ -135.9%Short Interest ⓘ 0.81MPerf YTD ⓘ 0.88%
Book/sh ⓘ 0.25P/C ⓘ 11.29EPS past 3/5Y ⓘ 18.01% 12.84%ROE ⓘ -179.24%52W High ⓘ -40.93% ($1.93)Perf Year ⓘ -8.06%
Cash/sh ⓘ 0.1P/FCF ⓘ -Sales past 3/5Y ⓘ -ROIC ⓘ -189.89%52W Low ⓘ 34.12% ($0.85)Perf 3Y ⓘ 0.01%
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ -5.19%Gross Margin ⓘ -Volatility(W/M) ⓘ 8.07% 7.39%Perf 5Y ⓘ -75.16%
Dividend TTM ⓘ -EV/Sales ⓘ -Sales Y/Y TTM ⓘ -Oper. Margin ⓘ -ATR (14) ⓘ 0.1Perf 10Y ⓘ -95.55%
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 0.95EPS Q/Q ⓘ -121.72%Profit Margin ⓘ -RSI (14) ⓘ 37.76Recom ⓘ 1
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 0.95Sales Q/Q ⓘ -SMA20 ⓘ -13.67% ($1.32)Beta ⓘ 1.83Target Price ⓘ $6
Payout ⓘ -Debt/Eq ⓘ 0Earnings ⓘ 2026/09/02SMA50 ⓘ -15.46% ($1.35)Rel Volume ⓘ 0.3Prev Close ⓘ $1.17
Employees ⓘ 7LT Debt/Eq ⓘ 0EPS/Sales Surpr. ⓘ -10% -SMA200 ⓘ -12.82% ($1.31)Avg Volume(3M) ⓘ 0.36MPrice ⓘ $1.14
IPO ⓘ 2004/8/12Option/Short ⓘ Yes/YesTrades ⓘ 248Volume ⓘ 106,808Change ⓘ -2.56%
Company
NNVC NNVCNanoViricides Inc | AMEX | Biotechnology Deep dive

Nanoviricides (NNVC) is a clinical-stage biotech developing broad-spectrum antivirals that combine nanotechnology with a host-mimetic strategy. Its lead candidate, NV-387, has entered Phase II clinical trials targeting MPox (monkeypox) and respiratory viruses, and NV-HHV-1 for shingles is also part of the pipeline.

Quote

Over the past 1 year, roughly in the middle

41% below its 1-year high.

Now $1.14
52w low$0.8552w high$1.93
52W Range27%
Volume ⓘ 106,808

Traded less than usual. That is 30% of its average volume.

D
Overall · many cautions
We judged 5 of the 8 questions below. 3 need caution.
No data for valuation, outlook, dividends, or not applicable.
ETFs holding this stock 4 ETFs

Multiple ETFs hold this stock, but only a sliver

Buying this ETF gives you exposure to this stock as well.

Peer comparison Biotechnology

It ranks #438 of 598 in the industry

Based on market cap of $29M.

FAQ

FAQ

NNVC belongs to the Healthcare sector and operates in the Biotechnology industry.

The market cap of NNVC is approximately $29M, ranking 5,002 within its sector.

NNVC has recorded a 52-week high of $1.93 and a low of $0.85.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels